drugset / Trial / NCT01833312

Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke

NCT01833312

Phase 3 Terminated 98 enrolled University of Erlangen-Nürnberg Medical School
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if systemic cooling to a target temperature of 34 to 35°C, started within 6 hours of symptom onset and maintained for 12 hours, improves functional outcome at 3 months in patients with acute ischaemic stroke.

Timeline

Start
2013-07
Primary completion
2018-07-31
Completion
2018-07-31

Drugs

EvaluationDrugModalityDoseRoute
Background Buspirone Small molecule
Background Meperidine Unknown

Indications